Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter February 24, 2014

Digoxin overdose – an accurate method for determining free digoxin concentrations on general chemistry analysers post DigiFab treatment

  • Goce Dimeski EMAIL logo , Brock Jones , Peter Pillans , Colin Page and Nigel N. Brown

Corresponding author: Goce Dimeski, Chemical Pathology, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Brisbane, QLD 4102, Australia, Phone: 61 7 31762290, Fax: 61 7 31767070, E-mail:


1. Haynes K, Heitjan D, Kanetsy P, Hennessy S. Declining public health burden of digoxin toxicity from 1991–2004. Clin Pharmacol Ther 2009;85:143–4.Search in Google Scholar

2. Medscape, Digitalis toxicity. Available from:–overview#a0156. Accessed 4 October, 2013.Search in Google Scholar

3. Dasgupta A. Impact of interferences including metabolite cross reactivity on therapeutic drug monitoring results. Ther Drug Monit 2012;34:496–506.10.1097/FTD.0b013e318261c2c9Search in Google Scholar

4. McMillan GA, Owen WE, Lambert TL, De BK, Frank EL, Bach PR, et al. Comparable effects of DIGIBIND and DigiFab in thirteen digoxin immunoassays. Clin Chem 2002;48:1580–4.10.1093/clinchem/48.9.1580Search in Google Scholar

5. Ingham KC. Protein precipitation with polyethylene glycol. Methods Enzymol 1984;104:351–6.10.1016/S0076-6879(84)04101-XSearch in Google Scholar

Received: 2013-12-3
Accepted: 2014-1-29
Published Online: 2014-2-24
Published in Print: 2014-7-1

©2014 by Walter de Gruyter Berlin/Boston

Downloaded on 21.2.2024 from
Scroll to top button